CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Chin Peter Scott Chief Medical Officer | Sale | −1,654 | $22.29 | $37K | 204,538 |
| 2026-09-02 | Thornberry Nancy Director | Sale 10b5-1 | −10,824 | $22.85 | $247K | 20,301 |
| 2026-09-02 | Thornberry Nancy Director | Sale 10b5-1 | −615 | $23.74 | $15K | 19,686 |
| 2026-09-01 | Schuth Alexander O. COFO and Secretary | Sale 10b5-1 | −2,768 | $23.44 | $65K | 278,995 |
| 2026-08-12 | Watts Ryan J. President and CEO | Gift | −32,220 | 2,120,384 | ||
| 2026-08-11 | Schuth Alexander O. COFO and Secretary | Sale | −2,857 | $25.07 | $72K | 281,763 |
| 2026-06-03 | Van Hauwermeiren Timothy Director | Grant or award | +6,408 | 17,040 | ||
| 2026-06-03 | Van Hauwermeiren Timothy Director | Grant or award · Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2026-06-03 | Thornberry Nancy Director | Grant or award | +6,408 | 31,125 | ||
| 2026-06-03 | Thornberry Nancy Director | Grant or award · Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2026-06-03 | Cook Jennifer E. Director | Grant or award | +6,408 | 32,483 | ||
| 2026-06-03 | Cook Jennifer E. Director | Grant or award · Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2026-06-03 | Krognes Steve E. Director | Grant or award | +6,408 | 38,202 | ||
| 2026-06-03 | Krognes Steve E. Director | Grant or award · Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2026-06-03 | Schenkein David P Director | Grant or award | +6,408 | 21,665 | ||
| 2026-06-03 | Schenkein David P Director | Grant or award · Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2026-06-03 | Klein Peter S Director | Grant or award | +6,408 | 33,941 | ||
| 2026-06-03 | Klein Peter S Director | Grant or award · Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2026-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award | +6,408 | 343,275 | ||
| 2026-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award | +6,408 | 3,422,366 |
Page 1 of 53 · 1,043 trades